With over 30 years of experience in Compliance and Legal, Mrs. Lacerca-Allen has been a leader in developing and implementing global compliance programs within Top Fortune 100 companies. She has extensive experience delineating compliance strategy, leading global teams and negotiating, implementing, and executing on corporate integrity agreements, deferred prosecution agreements and consent decrees.
About her
Fabiana Lacerca-Allen is the Senior Vice President of Compliance at Aimmune Therapeutics, a Nestle Health Science corporation, a biopharmaceutical company developing treatments for potentially life-threatening food allergies. She also currently serves as a Board of Director Member at Shield Therapeutics, and The Center of Excellence in Life and previously ArthoCare Corporation.
Prior to joining Aimmune Therapeutics, Mrs. Lacerca-Allen held several leadership positions at Elan Pharmaceuticals, Mylan Laboratories, Bristol Myers Squibb Company, Microsoft, Merck Sharp & Dohme, and AT&T Capital.
Mrs. Lacerca-Allen received her Juris Doctor degree from the Universidad de Buenos Aires and obtained her LLM degree from UCLA where she was the recipient of 1992 UCLA’s tuition waiver based on merit and recognition.
She has been recognized by Compliance Week as Top Minds 2019, Hispanic Executive Magazine as Legal Industry Leader and by The Guardian as Women in Leadership, Inspiring Leaders among other recognitions.
mflacerca@gmail.com
+1 (510) 913-0791
